COMPOSITION PHARMACEUTIQUE DESTINÉE À L'ADMINISTRATION PAR VOIE ORALE ET UTILE POUR LE TRAITEMENT DU SYNDROME DE L'INTESTIN IRRITABLE, CONSTITUÉE D'UN MODIFICATEUR DE LA MOTILITÉ INTESTINALE, D'UN AGENT EMPÊCHANT LA RÉTENTION DES GAZ ET D'ENZYMES DIGESTIVES, PROCÉDÉ DE PRÉPARATION DE LADITE COMPOSITION
The invention relates to a pharmaceutical formulation or composition intended to be administered orally in the form of a tablet, a coated tablet or a capsule, for the prevention or treatment of intestinal disorders, such as irritable bowel syndrome, comprising an intestinal motility modifier, an agent that prevents gas retention, digestive enzymes, a binding agent, a diluent, an adsorbent agent, a disintegrating agent, a lubricant and a glidant, effective for normalising colon transit, for providing an analgesic activity, for providing an antispasmodic activity and for reducing symptoms related to intestinal gas, such as distention, abdominal pain and flatulence.
